Influence of Waiting List in Recurrence Disease of Hepatocellular Carcinoma

Miguel, Carlos San; Vilchez, A.; Villegas, T.; Granero, Karim Muffak; Becerra, A.; López, María Rodríguez; Expósito, Manuela; Fundora, Y.

doi:10.1016/j.transproceed.2015.10.020

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the research focuses on the second perspective. 23 All these studies find that waiting longer is associated with improved post-transplant survival 3 , [24] , [25] , [26] , [27] , [28] or no harm. 29 , 30 Many acknowledge that the cause of this association has no oncological basis.…”

Section: Discussionmentioning

confidence: 99%

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group

Beumer¹,

Polak²,

Man³

et al. 2023

JHEP Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group

Beumer¹,

Polak²,

Man³

et al. 2023

JHEP Reports

View full text Add to dashboard Cite

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis

Bauschke

Altendorf-Hofmann

Ardelt

et al. 2020

J Cancer Res Clin Oncol

View full text Add to dashboard Cite

Background It has been shown that local ablative procedures enable downsizing, reduce drop-out from the waiting list and improve prognosis after liver transplantation. It is still unclear whether a response to the local ablative therapy is due to a favorable tumor biology or if a real benefit in tumor stabilization exists, particularly in complete pathological response. Method Data of 163 HCC patients who underwent liver transplantation were extracted from our prospectively maintained registry. We analyzed the tumor load, pre-transplant α-fetoprotein levels, child stage aside the application and success of local ablative therapies as bridging procedures before transplantation. Results 87 patients received multiple and/or combined local therapies. In 20 cases, this resulted in a complete remission of the tumor as observed in the explant histology. The other 76 patients underwent no bridging procedure. The observed 5- and 10-year survival rates for patients with bridging were 67% and 47% and without bridging 56% and 46%, respectively. Tumor-related 10-year survival showed a statistically significant difference between both groups (81% versus 59%). In the multivariate analyses bridging, number of lesions and α-fetoprotein level showed an independent statistically significant influence on tumor-related survival in these patients. Conclusions Successful local ablative therapy before liver transplantation is an independent statistically significant factor in long-term tumor-related survival for patients with HCC in cirrhosis and reduces tumor recurrences.

show abstract

Influence of Waiting List in Recurrence Disease of Hepatocellular Carcinoma

Cited by 2 publications

References 10 publications

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis

Contact Info

Product

Resources

About